Coromandel International Limited, one of India’s leading agri-solutions providers, announced its financial results for the quarter and nine months ended December 31, 2025.
The Company continues to strengthen its leadership across fertilisers, crop protection, bio-products, specialty nutrients, organic fertilisers and agri-retail while making notable advances in agri-drone spraying and other digital initiatives that drive sustainability and farm productivity.
Summary – Q3 Standalone Results
| In Rs Crores | 2024-25 | 2025-26 | % change |
| Total Income | 7,038 | 8,537 | 21% |
| EBITDA | 727 | 763 | 5% |
| PAT | 525 | 530 | 1% |
Summary – YTD Standalone Results
| In Rs Crores | 2024-25 | 2025-26 | % change |
| Total Income | 19,315 | 25,133 | 30% |
| EBITDA | 2,218 | 2,652 | 20% |
| PAT | 1,552 | 1,854 | 19% |
Consolidated Results
Coromandel’s Total Income for the quarter ended December 2025 was at Rs. 8,863 Cr vs. Rs. 7,049 Cr for the quarter ended December 2024. The Profit after tax for the quarter was at Rs. 488 Cr as against Rs. 508 Cr for the quarter ended December 2024.
Coromandel’s Total Income for YTD December 2025 was at Rs. 25,759 Cr vs. Rs. 19,330 Cr in the corresponding period of the previous year. The Profit after tax for YTD December 2025 was at Rs. 1,784 Cr as against Rs. 1,476 Cr in the corresponding period of the previous year.
Dividend
The Board in its meeting held today has approved interim dividend of Rs. 9/- per equity share, representing 900% on the face value of Rs. 1/- per equity share.
Commenting on the results, Mr S. Sankarasubramanian, MD & CEO, Coromandel International mentioned, “Coromandel delivered a resilient performance during the quarter despite a challenging business environment marked by late monsoon withdrawal, along with surge in raw material prices and sharp rupee depreciation. Company’s fertiliser plants operated at full capacity, delivering record quarterly production of 1.0 million tons of NPKs. Business maintained its market leadership in the phosphatic fertiliser segment, registering cumulative sales of 3.6 million tons and achieving 10% volume growth during the year.
The Crop Protection segment reported a strong performance, benefiting from favourable demand for its key molecules across export and domestic markets.
The Company’s Retail business continued to expand its footprint in existing and new geographies, with the addition of over 250 stores during the year.”
Nutrient and Allied Business
The Standalone Revenue for the quarter ended December 2025 was at Rs. 7,753 Cr as against Rs. 6,363 Cr for the quarter ended December 2024. Profit before interest and tax for the quarter was Rs. 615 Cr vs. Rs. 635 Cr in the corresponding period of the previous year.
The Standalone Revenue for YTD December 2025 was at Rs. 22,722 Cr compared with Rs. 17,307 Cr in the corresponding period of the previous year. Profit before interest and tax for YTD December 2025 was Rs. 2,250 Cr vs. Rs. 1,932 Cr in the corresponding period of the previous year.
Company’s backward integration projects – Sulphuric acid and Phosphoric acid plants – are progressing as per schedule and planned to be commissioned in Q4 FY26. The fertiliser capacity expansion project at Kakinada is progressing well and remains on track for completion in Q4 FY27.
During the quarter, Company, through its wholly owned subsidiary, has set up a joint venture company ‘Stuccoedge India Private Limited’ for manufacture and sale of Phospho-Gypsum based products. It has also initiated work for setting up water soluble fertiliser plant at Vizag.
Crop Protection Business
The Standalone Revenue for the quarter ended December 2025 was at Rs. 785 Cr as against Rs. 631 Cr for the quarter ended December 2024. Profit before interest and tax for the quarter was Rs. 158 Cr vs. Rs. 91 Cr in the corresponding period of the previous year.
The Standalone Revenue for YTD December 2025 was at Rs. 2,338 Cr compared with Rs. 1,937 Cr in the corresponding period of the previous year. Profit before interest and tax for YTD December 2025 was Rs. 431 Cr vs. Rs. 264 Cr in the corresponding period of the previous year.
The Company expanded capacity of its key technical molecule and is further working on additional capacity augmentation. During the quarter, the Company’s subsidiary, NACL Industries Limited, successfully completed a Rs 249 crore Rights Issue.
